Skip to main content
. 2018 Mar 23;2018(3):CD010840. doi: 10.1002/14651858.CD010840.pub2

Summary of findings 3. Cognitive‐behavioural therapy versus other non‐pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in adults.

Cognitive‐behavioural therapy versus other interventions for ADHD in adults
Patient or population: adults with ADHD
 Setting: ambulatory/hospital (outpatients)
 Intervention: CBT
 Comparison: other specific non‐pharmacological treatment
Outcomes Anticipated absolute effects* (95% CI) Relative effect
 (95% CI) № of participants
 (studies) Quality of the evidence
 (GRADE) Comments
Risk with control conditions Risk with CBT
ADHD symptoms: clinician‐rated
Assessed by: various scales
Follow‐up: 10 to 12 weeks
The mean ADHD clinician‐rated symptoms score in the intervention groups was 0.58 standardised deviations lower (0.98 lower to 0.17 lower) 97
 (2 RCTs) ⊕⊕⊝⊝
 Lowa Moderate effect sizeb
ADHD symptoms: self‐reported
Assessed by: various scales
Follow‐up: 8 to 12 weeks
The mean ADHD self‐reported symptoms score in the intervention groups was 0.44 standardised deviations lower (0.88 lower to 0.01 lower) 156
 (4 RCTs) ⊕⊕⊝⊝
 Lowa Small effect sizeb
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 ADHD: attention deficit hyperactivity disorder; CBT: cognitive‐behavioural therapy; CI: confidence interval.
GRADE Working Group grades of evidenceHigh quality: we are very confident that the true effect lies close to that of the estimate of the effect.
 Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
 Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
 Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

a We downgraded the quality of evidence because of imprecision (considering the width of the CI) and methodological limitations (due to the high risk of bias in blinding of participants and personnel and three other domains with unclear risk of bias).
 bTo assess the magnitude of effect for continuous outcomes, we used the criteria suggested by Cohen 1988: 0.2 represents a small effect, 0.5 a moderate effect, and 0.8 a large effect.